References
- Pichichero ME. Recurrent and persistent otitis media. Pediatr Infect Dis J 2000;19:911–16.
- Friel-Patti S, Finitzo T. Language learning in a prospective study of otitis media with effusion in the first two years of life. J Speech Hear Res 1990;33:188–94.
- Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992;11:S7–11.
- Chen R, Lim JH, Jono H, Gu XX, Kim YS, Basbaum CB, et al. Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF-kappaB signaling pathways. Biochem Biophys Res Commun 2004;324:1087–94.
- Lim JH, Jono H, Koga T, Woo CH, Ishinaga H, Bourne P, et al. Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice. PLoS One 2007;2:e1032.
- Lim JH, Kim HJ, Komatsu K, Ha U, Huang Y, Jono H, et al. Differential regulation of Streptococcus pneumoniae-induced human MUC5AC mucin expression through distinct MAPK pathways. Am J Transl Res 2009;1:300–11.
- Lim JH, Woo CH, Li JD. Critical role of type 1 plasminogen activator inhibitor (PAI-1) in early host defense against nontypeable Haemophilus influenzae (NTHi) infection. Biochem Biophys Res Commun 2011;414:67–72.
- Lee J, Komatsu K, Lee BC, Lim JH, Jono H, Xu H, et al. Phosphodiesterase 4B mediates extracellular signal-regulated kinase-dependent up-regulation of mucin MUC5AC protein by Streptococcus pneumoniae by inhibiting cAMP-protein kinase A-dependent MKP-1 phosphatase pathway. J Biol Chem 2012;287:22799–811.
- Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 2003;14:33–43.
- Sejima T, Madoiwa S, Mimuro J, Sugo T, Okada K, Ueshima S, et al. Protection of plasminogen activator inhibitor-1-deficient mice from nasal allergy. J Immunol 2005;174:8135–43.
- Li J, Eriksson PO, Hansson A, Hellstrom S, Ny T. Plasmin/plasminogen is essential for the healing of tympanic membrane perforations. Thromb Haemost 2006;96:512–19.
- Li F, Goncalves J, Faughnan K, Steiner MG, Pagan-Charry I, Esposito D, et al. Targeted inhibition of wound-induced PAI-1 expression alters migration and differentiation in human epidermal keratinocytes. Exp Cell Res 2000;258:245–53.
- Makishima K, Toriya Y, Inoue S, Nakashima T, Igarashi Y. Clinicopathologic studies in tympanosclerosis. Am J Otol 1982;3:260–5.
- Marshall LJ, Ramdin LS, Brooks T, DPhil PC, Shute JK. Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes. J Immunol 2003;171:2057–65.
- Renckens R, Roelofs JJ, Bonta PI, Florquin S, de Vries CJ, Levi M, et al. Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood 2007;109:1593–601.
- Russell JD, Giles JJ. Tympanosclerosis in the rat tympanic membrane: an experimental study. Laryngoscope 2002;112:1663–6.
- Xu Z, Castellino FJ, Ploplis VA. Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture. Blood 2010;115:2038–47.
- Salonen EM, Vaheri A, Meri S, Lehtinen T, Palva T. Plasmin and fibronectin degradation in chronic secretory otitis media. Arch Otolaryngol Head Neck Surg 1989;115:48–53.
- Lim JH, Stirling B, Derry J, Koga T, Jono H, Woo CH, et al. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity 2007;27:349–60.
- Shin SG, Koh SH, Lim JH. The in vivo and in vitro roles of epithelial pattern recognition receptors in pneumococcal infections. J Bacteriol Virol 2014;44:121–32.